Global Retinal Disease Therapeutics Market Growth (Status and Outlook) 2025-2031

September 2025 | 81 pages | ID: G73E46E0621EN
LP Information

Abstracts

According to this study, the global Retinal Disease Therapeutics market size will reach US$ million by 2031.

Retinal diseases vary widely, but most of them cause visual symptoms. Retinal diseases can affect any part of your retina, a thin layer of tissue on the inside back wall of your eye.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Retinal Disease Therapeutics Industry Forecast” looks at past sales and reviews total world Retinal Disease Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Retinal Disease Therapeutics sales for 2025 through 2031. With Retinal Disease Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Retinal Disease Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Retinal Disease Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Retinal Disease Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Retinal Disease Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Retinal Disease Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Retinal Disease Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of Retinal Disease Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Macular Degeneration
• Diabetic Macular Edema
• Diabetic Retinopathy
• Retinal Vein Occlusion

Segmentation by Application:

• Hospital Pharmacy
• Retail Pharmacy
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Merck
• Novartis
• Allergan
• Roche
• Regeneron
• Santen

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Retinal Disease Therapeutics Market Size (2020-2031)
  2.1.2 Retinal Disease Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Retinal Disease Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Retinal Disease Therapeutics Segment by Type
  2.2.1 Macular Degeneration
  2.2.2 Diabetic Macular Edema
  2.2.3 Diabetic Retinopathy
  2.2.4 Retinal Vein Occlusion
2.3 Retinal Disease Therapeutics Market Size by Type
  2.3.1 Retinal Disease Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Retinal Disease Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Retinal Disease Therapeutics Segment by Application
  2.4.1 Hospital Pharmacy
  2.4.2 Retail Pharmacy
  2.4.3 Others
2.5 Retinal Disease Therapeutics Market Size by Application
  2.5.1 Retinal Disease Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Retinal Disease Therapeutics Market Size Market Share by Application (2020-2025)

3 RETINAL DISEASE THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Retinal Disease Therapeutics Market Size Market Share by Player
  3.1.1 Global Retinal Disease Therapeutics Revenue by Player (2020-2025)
  3.1.2 Global Retinal Disease Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Retinal Disease Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RETINAL DISEASE THERAPEUTICS BY REGION

4.1 Retinal Disease Therapeutics Market Size by Region (2020-2025)
4.2 Global Retinal Disease Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Retinal Disease Therapeutics Market Size Growth (2020-2025)
4.4 APAC Retinal Disease Therapeutics Market Size Growth (2020-2025)
4.5 Europe Retinal Disease Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Retinal Disease Therapeutics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Retinal Disease Therapeutics Market Size by Country (2020-2025)
5.2 Americas Retinal Disease Therapeutics Market Size by Type (2020-2025)
5.3 Americas Retinal Disease Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Retinal Disease Therapeutics Market Size by Region (2020-2025)
6.2 APAC Retinal Disease Therapeutics Market Size by Type (2020-2025)
6.3 APAC Retinal Disease Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Retinal Disease Therapeutics Market Size by Country (2020-2025)
7.2 Europe Retinal Disease Therapeutics Market Size by Type (2020-2025)
7.3 Europe Retinal Disease Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Retinal Disease Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Retinal Disease Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Retinal Disease Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RETINAL DISEASE THERAPEUTICS MARKET FORECAST

10.1 Global Retinal Disease Therapeutics Forecast by Region (2026-2031)
  10.1.1 Global Retinal Disease Therapeutics Forecast by Region (2026-2031)
  10.1.2 Americas Retinal Disease Therapeutics Forecast
  10.1.3 APAC Retinal Disease Therapeutics Forecast
  10.1.4 Europe Retinal Disease Therapeutics Forecast
  10.1.5 Middle East & Africa Retinal Disease Therapeutics Forecast
10.2 Americas Retinal Disease Therapeutics Forecast by Country (2026-2031)
  10.2.1 United States Market Retinal Disease Therapeutics Forecast
  10.2.2 Canada Market Retinal Disease Therapeutics Forecast
  10.2.3 Mexico Market Retinal Disease Therapeutics Forecast
  10.2.4 Brazil Market Retinal Disease Therapeutics Forecast
10.3 APAC Retinal Disease Therapeutics Forecast by Region (2026-2031)
  10.3.1 China Retinal Disease Therapeutics Market Forecast
  10.3.2 Japan Market Retinal Disease Therapeutics Forecast
  10.3.3 Korea Market Retinal Disease Therapeutics Forecast
  10.3.4 Southeast Asia Market Retinal Disease Therapeutics Forecast
  10.3.5 India Market Retinal Disease Therapeutics Forecast
  10.3.6 Australia Market Retinal Disease Therapeutics Forecast
10.4 Europe Retinal Disease Therapeutics Forecast by Country (2026-2031)
  10.4.1 Germany Market Retinal Disease Therapeutics Forecast
  10.4.2 France Market Retinal Disease Therapeutics Forecast
  10.4.3 UK Market Retinal Disease Therapeutics Forecast
  10.4.4 Italy Market Retinal Disease Therapeutics Forecast
  10.4.5 Russia Market Retinal Disease Therapeutics Forecast
10.5 Middle East & Africa Retinal Disease Therapeutics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Retinal Disease Therapeutics Forecast
  10.5.2 South Africa Market Retinal Disease Therapeutics Forecast
  10.5.3 Israel Market Retinal Disease Therapeutics Forecast
  10.5.4 Turkey Market Retinal Disease Therapeutics Forecast
10.6 Global Retinal Disease Therapeutics Forecast by Type (2026-2031)
10.7 Global Retinal Disease Therapeutics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Retinal Disease Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Merck
  11.1.1 Merck Company Information
  11.1.2 Merck Retinal Disease Therapeutics Product Offered
  11.1.3 Merck Retinal Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Merck Main Business Overview
  11.1.5 Merck Latest Developments
11.2 Novartis
  11.2.1 Novartis Company Information
  11.2.2 Novartis Retinal Disease Therapeutics Product Offered
  11.2.3 Novartis Retinal Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Novartis Main Business Overview
  11.2.5 Novartis Latest Developments
11.3 Allergan
  11.3.1 Allergan Company Information
  11.3.2 Allergan Retinal Disease Therapeutics Product Offered
  11.3.3 Allergan Retinal Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Allergan Main Business Overview
  11.3.5 Allergan Latest Developments
11.4 Roche
  11.4.1 Roche Company Information
  11.4.2 Roche Retinal Disease Therapeutics Product Offered
  11.4.3 Roche Retinal Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Roche Main Business Overview
  11.4.5 Roche Latest Developments
11.5 Regeneron
  11.5.1 Regeneron Company Information
  11.5.2 Regeneron Retinal Disease Therapeutics Product Offered
  11.5.3 Regeneron Retinal Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Regeneron Main Business Overview
  11.5.5 Regeneron Latest Developments
11.6 Santen
  11.6.1 Santen Company Information
  11.6.2 Santen Retinal Disease Therapeutics Product Offered
  11.6.3 Santen Retinal Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Santen Main Business Overview
  11.6.5 Santen Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Retinal Disease Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Retinal Disease Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Macular Degeneration
Table 4. Major Players of Diabetic Macular Edema
Table 5. Major Players of Diabetic Retinopathy
Table 6. Major Players of Retinal Vein Occlusion
Table 7. Retinal Disease Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Retinal Disease Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Retinal Disease Therapeutics Market Size Market Share by Type (2020-2025)
Table 10. Retinal Disease Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Retinal Disease Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Retinal Disease Therapeutics Market Size Market Share by Application (2020-2025)
Table 13. Global Retinal Disease Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Retinal Disease Therapeutics Revenue Market Share by Player (2020-2025)
Table 15. Retinal Disease Therapeutics Key Players Head office and Products Offered
Table 16. Retinal Disease Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Retinal Disease Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Retinal Disease Therapeutics Market Size Market Share by Region (2020-2025)
Table 21. Global Retinal Disease Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Retinal Disease Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Retinal Disease Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Retinal Disease Therapeutics Market Size Market Share by Country (2020-2025)
Table 25. Americas Retinal Disease Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Retinal Disease Therapeutics Market Size Market Share by Type (2020-2025)
Table 27. Americas Retinal Disease Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Retinal Disease Therapeutics Market Size Market Share by Application (2020-2025)
Table 29. APAC Retinal Disease Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Retinal Disease Therapeutics Market Size Market Share by Region (2020-2025)
Table 31. APAC Retinal Disease Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Retinal Disease Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Retinal Disease Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Retinal Disease Therapeutics Market Size Market Share by Country (2020-2025)
Table 35. Europe Retinal Disease Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Retinal Disease Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Retinal Disease Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Retinal Disease Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Retinal Disease Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Retinal Disease Therapeutics
Table 41. Key Market Challenges & Risks of Retinal Disease Therapeutics
Table 42. Key Industry Trends of Retinal Disease Therapeutics
Table 43. Global Retinal Disease Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Retinal Disease Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Retinal Disease Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Retinal Disease Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Merck Details, Company Type, Retinal Disease Therapeutics Area Served and Its Competitors
Table 48. Merck Retinal Disease Therapeutics Product Offered
Table 49. Merck Retinal Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Merck Main Business
Table 51. Merck Latest Developments
Table 52. Novartis Details, Company Type, Retinal Disease Therapeutics Area Served and Its Competitors
Table 53. Novartis Retinal Disease Therapeutics Product Offered
Table 54. Novartis Retinal Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Novartis Main Business
Table 56. Novartis Latest Developments
Table 57. Allergan Details, Company Type, Retinal Disease Therapeutics Area Served and Its Competitors
Table 58. Allergan Retinal Disease Therapeutics Product Offered
Table 59. Allergan Retinal Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Allergan Main Business
Table 61. Allergan Latest Developments
Table 62. Roche Details, Company Type, Retinal Disease Therapeutics Area Served and Its Competitors
Table 63. Roche Retinal Disease Therapeutics Product Offered
Table 64. Roche Retinal Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Roche Main Business
Table 66. Roche Latest Developments
Table 67. Regeneron Details, Company Type, Retinal Disease Therapeutics Area Served and Its Competitors
Table 68. Regeneron Retinal Disease Therapeutics Product Offered
Table 69. Regeneron Retinal Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Regeneron Main Business
Table 71. Regeneron Latest Developments
Table 72. Santen Details, Company Type, Retinal Disease Therapeutics Area Served and Its Competitors
Table 73. Santen Retinal Disease Therapeutics Product Offered
Table 74. Santen Retinal Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Santen Main Business
Table 76. Santen Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Retinal Disease Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Retinal Disease Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Retinal Disease Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Retinal Disease Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Retinal Disease Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Retinal Disease Therapeutics Market Size Market Share by Type in 2024
Figure 10. Retinal Disease Therapeutics in Hospital Pharmacy
Figure 11. Global Retinal Disease Therapeutics Market: Hospital Pharmacy (2020-2025) & ($ millions)
Figure 12. Retinal Disease Therapeutics in Retail Pharmacy
Figure 13. Global Retinal Disease Therapeutics Market: Retail Pharmacy (2020-2025) & ($ millions)
Figure 14. Retinal Disease Therapeutics in Others
Figure 15. Global Retinal Disease Therapeutics Market: Others (2020-2025) & ($ millions)
Figure 16. Global Retinal Disease Therapeutics Market Size Market Share by Application in 2024
Figure 17. Global Retinal Disease Therapeutics Revenue Market Share by Player in 2024
Figure 18. Global Retinal Disease Therapeutics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Retinal Disease Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. APAC Retinal Disease Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Europe Retinal Disease Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Retinal Disease Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Americas Retinal Disease Therapeutics Value Market Share by Country in 2024
Figure 24. United States Retinal Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Retinal Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Retinal Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Retinal Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Retinal Disease Therapeutics Market Size Market Share by Region in 2024
Figure 29. APAC Retinal Disease Therapeutics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Retinal Disease Therapeutics Market Size Market Share by Application (2020-2025)
Figure 31. China Retinal Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Retinal Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Retinal Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Retinal Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Retinal Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Retinal Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Retinal Disease Therapeutics Market Size Market Share by Country in 2024
Figure 38. Europe Retinal Disease Therapeutics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Retinal Disease Therapeutics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Retinal Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Retinal Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Retinal Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Retinal Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Retinal Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Retinal Disease Therapeutics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Retinal Disease Therapeutics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Retinal Disease Therapeutics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Retinal Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Retinal Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Retinal Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Retinal Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Retinal Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. APAC Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. Europe Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. United States Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Canada Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. China Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Japan Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Korea Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. India Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Australia Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Germany Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. France Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. UK Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Italy Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Russia Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Israel Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Global Retinal Disease Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Retinal Disease Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Retinal Disease Therapeutics Market Size 2026-2031 ($ millions)